Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-07-07
1991-09-24
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 3178
Patent
active
050512536
ABSTRACT:
A method for the treatment of inflammatory bowel disease which comprises administering to a patient an effective oral or rectal amount of a polyacrylate. There are also described compositions for use in the method.
REFERENCES:
patent: 2909462 (1959-10-01), Warfield et al.
patent: 3930005 (1975-12-01), Wojnor et al.
patent: 4273761 (1981-06-01), Matsuda et al.
patent: 4705683 (1987-11-01), Dettmar
Marshall, "The Isolation and Characterization of the High-Molecular-Weight Glycoprotein from Pig Colonic Mucus", Biochem J. (1978), 173, 569-578.
Ishii, "Effects of Sodium Polyacrylate (PANa) on Peptic Ulcers in Rats", Oyo Yakuri (1982) 23 (1) 55-62.
Hill, "The Possible Role of Bacteria in Inflammatory Bowel Disease", Current Concepts in Gastroenterology, Winter 1985, pp. 8-13.
Dettmar Peter W.
Lloyd-Jones John G.
Cashion Jr. Merrell C.
Kulkosky Peter F.
Reckitt & Colman Products Limited
LandOfFree
Use of polyacrylates to reduce proteolytic activity in the human does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of polyacrylates to reduce proteolytic activity in the human, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of polyacrylates to reduce proteolytic activity in the human will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1695400